GSK-3β-mediated regulation of Nrf2/HO-1 signaling as a new therapeutic approach in the treatment of movement disorders
Crossref DOI link: https://doi.org/10.1007/s43440-022-00390-z
Published Online: 2022-07-26
Published Print: 2022-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Soni, Divya
Kumar, Puneet http://orcid.org/0000-0002-7978-1043
Text and Data Mining valid from 2022-07-26
Version of Record valid from 2022-07-26
Article History
Received: 11 May 2022
Revised: 9 July 2022
Accepted: 12 July 2022
First Online: 26 July 2022
Declarations
:
: Authors declare no conflict of interest.